Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor
Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
How Will the FDA Regulate Generative AI in Medical IoT?
Management & Regulatory How Will the FDA Regulate Generative AI in Medical IoT?

Pre-market evaluation is no longer a one-time approval but the start of a continuous monitoring process to prevent performance drift in GenAI-enabled medical equipment. Hospitals across the United States are witnessing a silent revolution where the stethoscope is being augmented by vast neural

Quantum-Classical Hybrid Computing Speeds Up Drug Discovery
Tech & Innovation Quantum-Classical Hybrid Computing Speeds Up Drug Discovery

Standard quantum optimization methods typically require one qubit for every variable, a demand that quickly exceeds the capacity of current hardware. In the high-stakes world of pharmaceutical research, molecular docking serves as a critical tool for identifying how new drug candidates interact

New Tool Validates Medical Imaging Without a Gold Standard
Tech & Innovation New Tool Validates Medical Imaging Without a Gold Standard

The scalability of NGSE-Corr suggests that the method becomes increasingly powerful and reliable when applied to large-scale clinical datasets and patient populations. This innovative approach addresses a fundamental limitation in modern medical diagnostics where the push for quantitative data

WuXi Biologics Leads Industry in Sustainable Biopharma Innovation
Management & Regulatory WuXi Biologics Leads Industry in Sustainable Biopharma Innovation

Securing an MSCI AAA ESG rating and an EcoVadis Platinum Medal places WuXi Biologics in the top 1% of companies evaluated for environmental and social governance. This landmark achievement underscores the organization's role as a dominant force in the global healthcare market, particularly as it

Hims & Hers Navigates FTC Lawsuit and Strategic Pivot
Management & Regulatory Hims & Hers Navigates FTC Lawsuit and Strategic Pivot

Hims & Hers is currently navigating a complex period of transition as it trades its historical high-margin profile for a dominant position in the weight-loss sector. Operating at a volatile crossroads where rapid corporate expansion meets intense federal oversight, the leading telehealth platform

How Can We Prevent Off-Target mRNA Delivery to the Liver?
Research & Development How Can We Prevent Off-Target mRNA Delivery to the Liver?

A newly developed molecular shield consisting of a positively charged oligopeptide linked to two polyethylene glycol chains can transiently block the entry points of the liver. This innovation addresses a fundamental limitation in the field of genetic medicine, where the immense potential of

Can AI Bridge the Industrial Biomanufacturing Gap?
Biotech & Bioprocessing Can AI Bridge the Industrial Biomanufacturing Gap?

The maturation of artificial intelligence in the life sciences is now being judged by its ability to facilitate commercial execution rather than just generating digital designs. The recent acquisition of the American biotechnology firm Genomatica by Copenhagen-based Again signals a tectonic shift

Severe Mental Illness Raises Early Dementia and Stroke Risk
Tech & Innovation Severe Mental Illness Raises Early Dementia and Stroke Risk

The clinical perception that neurological decay remains a distant threat for the young has been shattered by evidence that psychiatric struggles can accelerate the biological clock significantly. For decades, the medical community viewed dementia and stroke as the "graying" of the brain, a concern

Can Targeting PHGDH Overcome Thyroid Cancer Drug Resistance?
Research & Development Can Targeting PHGDH Overcome Thyroid Cancer Drug Resistance?

Research into anaplastic thyroid carcinoma suggests that blocking the enzyme PHGDH may effectively close the metabolic escape routes that facilitate resistance to targeted therapies. This aggressive form of thyroid cancer remains one of the most lethal malignancies, characterized by its rapid

Can AI Digital Twins Revolutionize Precision Oncology?
Tech & Innovation Can AI Digital Twins Revolutionize Precision Oncology?

Utilizing a Visual-Global Relation Fusion Network enables the discovery of crucial pathological connections that define a patient's biological response to diverse chemotherapy regimens. This breakthrough represents a seismic shift in modern oncology, moving away from the conventional

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later